海外の治験の状況「前立腺癌」での検索結果
31件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
- Prostate Cancer
- Australia, Austria, Belgium, Brazil, Denmark, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Spain, United Kingdom, United States
- 2017-05-09
Recruiting
- Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
- Metastatic Prostate Cancer
- Australia, Austria, Belgium, Brazil, Canada, China, Costa Rica, Denmark, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Norway, Poland, Portugal, Russian Federation, Slovenia, Spain, Taiwan, Thailand, United Kingdom, United States
- 2017-03-02
Recruiting
- A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy
- Metastatic Castrate Resistant Prostate Cancer;C61 - Malignant neoplasm of prostate
- Austria, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, France, Germany, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Turkey, United Kingdom, United States
- 2014-11-13
Recruiting
- A Randomized, Double Blind, Placebo-Controlled, Phase IIIb Study of the Efficacy and Safety of Continuing Enzalutamide in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer Patients Treated With Docetaxel Plus Prednisolone Who Have Progressed on Enzalutamide Alone
- Metastatic Castration Resistant Prostate Cancer;C61 - Malignant neoplasm of prostate
- Austria, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, Switzerland, Turkey, United Kingdom
- 2015-06-25
Recruiting
- Multicentric, prospective, randomized study to evaluate the effect of standard drug therapy with or without radical prostatectomy (RP) in patients with limited bone metastatic prostate cancer
- ;C61 - Malignant neoplasm of prostate
- Austria, Germany, Sweden
- 2015-10-02
Recruiting
- A Phase III, Multicenter, Randomized Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide Versus Enzalutamide Alone in Patients With Metastatic Castration-Resistant Prostate Cancer After Failure of an Androgen Synthesis Inhibitor and Failure of, Ineligibility for, or Refusal of a Taxane Regimen
- Prostatic Neoplasms, Castration-Resistant;C61 - Malignant neoplasm of prostate
- Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Switzerland, Taiwan, Province of China, United Kingdom, United States
- 2017-07-17
Recruiting
- EFFICACY AND SAFETY OF AB1010 IN COMBINATION WITH DOCETAXEL TO PLACEBO IN COMBINATION WITH DOCETEXAL IN FIRST LINE METASTATIC CASTRATE RESISTANT PROSTATE CANCER (mCRPC)
- first line metastatic Castrate Resistant Prostate Cancer (mCRPC)
- Austria, Canada, Czech Republic, France, Germany, India, Poland, Slovakia, Taiwan, United States of America
- 2015-10-14
Recruiting
- PRospective Prostate biOmarker Study
- Indication for Prostate Biopsy Due to Suspected Prostate Cancer
- Austria, Denmark, Germany
- 2018-06-07
Recruiting
- The role of intra-operative flow rate during prostate resection
- benign prostatic hyperplasia;Prostate cancer; br>benign prostatic hyperplasia Prostate cancer;Surgery - Surgical techniques;Cancer - Prostate;Renal and Urogenital - Other renal and urogenital disorders
- New Zealand
- 2018-12-05
Recruiting
- Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
- Metastatic Breast Cancer;Metastatic Prostate Cancer;Bone Metastases
- Austria, Germany, Switzerland
- 2014-01-29